Transcriptome-wide identification of mRNAs and lincRNAs associated with trastuzumab-resistance in HER2-positive breast cancer

Approximately, 25–30% of early-stage breast tumors are classified at the molecular level as HER2-positive, which is an aggressive subtype of breast cancer. Amplification of the HER2 gene in these tumors results in a substantial increase in HER2 mRNA levels, and consequently, HER2 protein levels. HER...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Merry, Callie R., McMahon, Sarah, Forrest, Megan E., Bartels, Cynthia F., Saiakhova, Alina, Bartel, Courtney A., Scacheri, Peter C., Thompson, Cheryl L., Jackson, Mark W., Harris, Lyndsay N., Khalil, Ahmad M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2016
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5288181/
https://ncbi.nlm.nih.gov/pubmed/27449296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10637
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk